• Profile
Close

Effect of moderate vs mild therapeutic hypothermia on mortality and neurologic outcomes in comatose survivors of out-of-hospital cardiac arrest: The CAPITAL CHILL randomized clinical trial

JAMA Oct 23, 2021

Le May M, Osborne C, Russo J, et al. - Researchers investigated the effect of moderate (target temperature of 31 °C) vs mild hypothermia (target temperature of 34 °C) on the rate of death or poor neurologic outcome in comatose survivors of out-of-hospital cardiac arrest.

  • Single-center, double-blind, randomized, clinical superiority trial including 367 adults with out-of-hospital cardiac arrest.

  • Patients randomized to receive hypothermia treatment at 31 °C vs 34 °C had 180-day all-cause mortality or poor neurologic outcome of 48.4% vs 45.4%, respectively; no statistically significant value of this difference was evident.

  • Overall there appeared no significant reduction in the rate of death or poor neurologic outcome among comatose survivors of out-of-hospital cardiac arrest at 180 days in correlation with a target temperature of 31 °C vs 34 °C.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay